Skip to content

Efficacy of Schema-Focused Therapy versus Usual Treatment in Forensic Patients with Personality Disorders: A Three-Year Randomized Clinical Trial

Efficacy of Schema-Focused Therapy versus Usual Treatment in Forensic Patients with Personality Disorders: A Three-Year Randomized Clinical Trial - Schematherapy in Forensic Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30603
Enrollment
100
Registered
2006-11-07
Start date
2007-01-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

personality disorders personality problems

Interventions

SFT is an integrative form of psychotherapy that combines cognitive, behavioral, psychodynamic object relations, and humanistic/existential approaches (Young et al., 2003). Unlike most other forms o
Young et al., 2003). The control therapy will consist of *Treatment as Usual (TAU).* TAU is defined as whatever form of verbal therapy is usually given at the participating institutions. This may i

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: DSM-IV Antisocial, Borderline, Narcissistic or Paranoid Personality Disorder, and TBS status

Exclusion criteria

Exclusion criteria: Exclusion criteria are (a) the presence of a current psychotic symptoms, (b) schizophrenia or bipolar disorder, (c) current drug or alcohol dependence (but not abuse), (d) low intelligence (i.e., Full Scale IQ

Design outcomes

Primary

MeasureTime frame
The primary outcome measures in this study are the severity of personality disorder symptoms and risk of recidivism and violence. To circumvent the problem of patients* tendency to *fake good,* we will base our assessments on observations of patients* behavior provided by knowledgeable staff members, rather than on patients* own self-reports. We hypothesize the patients receiving SFT will show reduced levels of personality disorder symptoms and reduced risk of violence and recidivism, compared with patients receiving TAU. We also hypothesize that patients receiving SFT will show better treatment engagement and retention, and have a more positive therapeutic alliance, compared to patients receiving TAU. Finally, we predict that SFT patients will show greater improvements in the maladaptive schemas and related psychological processes that are hypothesized to underlie personality disorders in the SFT model. In a future study, we will follow-up these patients to determine their risk of actual recidivism after some of them are released to the community.

Secondary

MeasureTime frame
As secondary outcome measures, we will assess differences between the two treatment conditions in therapy process variables (e.g., therapeutic engagement, quality of the therapeutic alliance), and changes in the psychological processes (i.e., Early Maladaptive Schemas, Schema Modes) that are hypothesized to mediate changes in personality disorders in the Schema Focused Therapy model.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)